Premium
Quality of Life and Cost for Patients with Premature Ventricular Contractions by Radiofrequency Catheter Ablation
Author(s) -
HUANG CONGXIN,
LIANG JINJUN,
YANG BO,
JIANG HONG,
TANG QIZHU,
LIU XIUJUAN,
WAN WEIGUO,
JIAN XIAOLI
Publication year - 2006
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.2006.00351.x
Subject(s) - medicine , radiofrequency catheter ablation , ambulatory , quality of life (healthcare) , catheter ablation , ablation , refractory (planetary science) , cardiology , emergency medicine , intensive care medicine , physics , nursing , astrobiology
Objective: To evaluate the quality of life (QoL), health‐care resource utilization, and cost for the patients with premature ventricular contractions (PVCs) by radiofrequency catheter ablation (RFCA).Methods: RFCA was performed in 58 patients with symptomatic PVCs that were refractory/easy to medication. A 24‐hour ambulatory electrocardiographic monitoring, QoL, health‐care resources utilization, and cost were assessed at a screening visit and 3 and 12 months after RFCA.Results: RFCA was successfully performed in 56 patients (96.6%). This resulted in a significant improvement in the QoL at 3 and 12 months after the procedure. There were no major complications related to the procedure. Nine patients (15.5%) had residual arrhythmia. Seven of them underwent repeated ablation with successful results. It also improved the QoL and reduced health‐care resource utilization and cost.Conclusions: RFCA is a safe and effective treatment for PVCs, and it is a viable alternative to drugs in the presence of disabling symptoms.